Figures & data
Figure 2. Graph in PPC with longitudinal overview of treatment effects including clinical assessment and Patient Reported Outcome Measures (PROM).
![Figure 2. Graph in PPC with longitudinal overview of treatment effects including clinical assessment and Patient Reported Outcome Measures (PROM).](/cms/asset/abcc829f-bbc7-4d5c-9e2a-225e1eddbf71/isju_a_1756402_f0002_c.jpg)
Table 1. Characteristics of men in Patient -overview Prostate Cancer (PPC) at date of prostate cancer diagnosis, date of start of secondary androgen deprivation therapy by use of data in Prostate Cancer data Base (PCBaSe) v 4.1 and at date of start of androgen receptor targeted drug by use of data in PPC according to primary treatment.
Table 2. Characteristics of men in Prostate Cancer database Sweden (PCBaSe) 4.1 treated with Androgen Receptor Targeted drugs in 2016–2017 according to filled prescriptions in the Prescribed Drug Registry and stratified according to registration or not in Patient-overview Prostate Cancer (PPC).